Compass Therapeutics, Inc. (CMPX) stock
CMPXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.82−0.01 (-1.23%)
Close on Nov 12, 2026Market cap $147.67MP/E –Yield –
Compass Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Compass Therapeutics's market cap was $149.51M on Nov 11, 2026, against $1.03B a year earlier. Over the last 5 years it ranged from $108.08M to $1.14B, with a median of $290.39M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $149.51M | -84.3% |
| 2025 | Dec 31, 2025 | $953.56M | +378.0% |
| 2024 | Dec 31, 2024 | $199.50M | +0.3% |
| 2023 | Dec 29, 2023 | $198.81M | -60.9% |
| 2022 | Dec 30, 2022 | $508.19M | +159.6% |
| 2021 | Dec 31, 2021 | $195.78M | – |
See a number that looks wrong?